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Abstract
The effect of ATP-depletion or its consequence, by metabolic inhibition, on the inhibition of glucose transport by various
inhibitors was studied in human red cells. In cells depleted of ATP, glucose exit times were longer than in normal cells and
the times increased with the duration of depletion. The K for external glucose was higher in ATP-depleted cells than inm
 .normal undepleted cells 3.0 mM c.f. 2.5 mM at 308C . In contrast, the apparent K for cytochalasin B decreased fromi
0.85 mM in the normal cells to 0.5 mM after ATP-depletion. Half-maximal rates of glucose exit in the absence, and in the
presence of 2 mM cytochalasin B were found at ATP concentrations of 0.43 and 0.68 mM, respectively. Although glucose
 .exits from ATP-depleted cells exposed to the irreversible inhibitor of glucose transport, 1-fluoro-2,4-dinitrobenzene FDNB
were slower than in normal cells, the relative degrees of inhibition were not significantly different. However, normal and
ATP-depleted cells responded differently to treatment with 1,2-cyclohexanedione, a modifier of arginine residues which
inhibits glucose exit. While normal cells were markedly inhibited, depleted cells were much less affected and the inhibitory
effect of cytochalasin B seen in normal cells was reduced. These findings demonstrate that the glucose transport system of
human red cells is affected by intracellular ATP and that ATP alters the affinity of the transporter for certain inhibitors. The
implications of these findings are discussed. q 1998 Elsevier Science B.V.
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1. Introduction
The glucose transport system in human erythro-
cytes is usually regarded as the epitome of a passive
transporter, requiring no input of metabolic energy in
order to function. However, there have been several
reports in the literature, of the modulation of glucose
w xtransport in red blood cells by ATP 1–3 .
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w xJaquez 1 reported that the depletion of energy
stores in human red cells decreased their maximum
capacity for glucose transport to a value of one-third
or less of that found in red cells from freshly drawn
w x w xblood and Weiser et al. 2 and Jensen and Brahm 3 ,
using outdated bank blood, also found a reduction in
the permeability for glucose, albeit less marked. Car-
w xruthers and Melchior 4 found that the transporter
behaved asymmetrically in the presence of a cytoso-
w xlic factor which Hebert and Carruthers 5 demon-
strated could be ATP.
In a series of detailed experiments, Carruthers et
w xal. 5–7 examined the effect of ATP on the glucose
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transporter and showed that the changes it produced
were due to an activation of transporters rather than a
recruitment and that ATP was bound but not hydrol-
ysed in the process. Further, it was shown that the
effect is only produced by ATP and some synthetic
.analogues and not by ADP and AMP, although these
nucleotides are also able to bind to the transporter.
However, there were conflicting reports in the
literature as to the kinetic effects of ATP. Thus,
w xalthough both Jacquez 1 and Carruthers and Helger-
w xson 7 found that ATP increased the rate of sugar
entry into red cells and ghosts, respectively, Jaquez
interpreted the effect as due to an increase in Vmax
while Carruthers and Helgerson suggested that it was
due to a decrease in K and V . Furthermore,m max
w xCarruthers 6 reported that in resealed ghosts, con-
taining ATP, the K for the net efflux of glucosem
was 28 mM and fell to 10 mM when ATP was absent,
w xwhile in contrast, Jensen and Brahm 3 found that
the K for net efflux increased from 1.3 mM inm
freshly drawn red cells to 14 mM in ghosts having
-200 mM ATP. These, and other anomalies, led
w xWheeler 8 to reinvestigate the effect of ATP using
glucose transporters reconstituted in liposomes and
he was unable to show any change in transport
beyond a generalised inhibition in the presence of
ATP. However, there are shortcomings with this
w xapproach 7 , including the fact that these experi-
ments were done in low ionic-strength media which
might have affected the normal ionic interactions
between the molecules.
Thus, the weight of evidence supports the view
that ATP does modify the behaviour of the glucose
transporter, but the precise effect of ATP on glucose
transport is still unresolved and if an effect does
exist, it raises two obvious questions. Firstly, what is
ATP doing to the transporter and, secondly, what is
its physiological role?
The properties of the glucose transport system in
red cells has been widely studied for reviews, see
w x.Refs. 9,10 . Following the determination of the
w xamino acid sequence 11 and a possible operating
w xmechanism of glucose transporter 12 , Widdas and
w xBaker 13 proposed the existence of a cationic shield
or gate at the inner end of the transport pathway. This
gate consisted of eight highly-conserved arginine
residues, arranged in a ring. Each arginine carries a
positive charge which was assumed to reside on one
of the terminal h-nitrogens. In this position, there
would be a strong positive electric field which would
repel potassium ions and prevent them from entering
the transporter cleft. However, if the charges should
move to the «-nitrogen of the arginines, the electric
repulsion would markedly decrease and potassium
could pass through the ring with relative ease. Shortly
after publication of this idea, Widdas and Baker
reported experiments in which an over-shrinkage of
red cells, due to a loss of potassium, was recorded
w xfollowing glucose exits 14 . They interpreted these
results as indicating the opening of the cationic gate.
w xRecent experiments in this laboratory 15 have con-
firmed that arginine residues have a role in prevent-
ing potassium loss via the glucose transporter.
Calculations of the energy for the transition be-
tween the closed and opened states of the gate showed
that it was sufficiently low so that some mechanism
w xwould be necessary to keep the gate closed 14 . It
was, therefore, proposed that during the conforma-
tional change in the transport cycle, a strong anion
was brought into the vicinity of the ring, thereby
pulling the positive charges onto the terminal nitro-
gens. From a consideration of the size of the ring and
the number of charges involved, it was suggested that
ATP could be this anion and, thus, it was envisaged
that during that half of the transport cycle when the
transporter was in the outward-facing conformation,
ATP was inserted into the ring and then, as the
conformation changed, it was withdrawn, leaving the
ring ‘closed’ to cations but not, of course, to un-
charged glucose. Thus, a possible role for ATP in
glucose transporter function has been identified.
Studies of the kinetics of the glucose transport
system in human red cells is complicated by the
w xapparent multiplicity of operational parameters 16,10
and, at present, there is no consensus as to what the
various parameters are measuring. Furthermore, any
change in the occupancy of the transporter will lead
to redistribution effects, further complicating the ki-
netics of transfer. It is thus likely to be very difficult
to ascribe specific kinetic effects to the binding of
ATP. Therefore, rather than trying to investigate the
effect of ATP on the transport of glucose, we decided
to examine the effect of ATP-depletion on the bind-
ing of various glucose transport inhibitors, as this
might allow a somewhat easier interpretation. The
side of the transporter at which binding occurs is
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known for a number of inhibitors. Glucose transport
is particularly sensitive to cytochalasin B, which
binds to the cytoplasmic surface of the transporter
w x17 and to phloretin, which binds at the external
w x w xsurface 18 . Baker and Widdas 19 demonstrated
that the specific arginine reagent, 1,2-cyclohexaned-
ione, inhibits glucose exits in human erythrocytes and
that its reaction is at the cytoplasmic side of the
w xtransporter, while Krupka 20 showed that the bind-
ing of fluorodinitrobenzene is enhanced during the
conformational change. We, therefore, examined the
inhibition of glucose transport caused by these in-
hibitors using the technique described by Sen and
w x  .Widdas 21 in which the infinite-cis exit of glucose
from the cells is measured. This technique was ap-
plied to normal cells and to metabolically inhibited
cells, on the assumption that the effects would be due
to the depletion of ATP.
2. Materials and methods
2.1. Preparation of cells
Blood from normal healthy donors was drawn into
heparinised tubes. For most experiments, the blood
was divided into two aliquots. One was placed in the
refrigerator for use as normal cells on the following
day and the other was washed three times with
phosphate-buffered saline NaCl, 120 mM; KCl,
.5 mM; NaH PO , 20 mM; pH 7.4 , the plasma and2 4
buffy coat being removed. The cells were then treated
w xaccording to Lew 22 to deplete ATP. Thereafter,
1.3 ml of the washed cells were incubated in 20 ml of
phosphate-buffered saline in the presence of 5 mM
iodoacetamide and 5 mM inosine at 208C for 18 h. At
the end of this time, the cells were washed again and
resuspended in phosphate-buffered saline. The other
aliquot of cells were now washed thrice with phos-
phate-buffered saline after which both normal and
ATP-depleted cells were treated similarly.
2.2. Experimental procedure
For glucose exits, two suspensions of cells, one
normal and one ATP-depleted, were pre-incubated at
308C for a minimum of 30 min in 100 mM glucose at
an haematocrit of 2%. Exit rates were measured as
w xdescribed by Sen and Widdas 23 . Then, 21 ml of
phosphate buffered saline were placed in the cuvette
w xof the photometer 24 , the chart recorder started, and
0.15 ml of cell suspension, containing ;3 ml cells,
injected into the cuvette. The shrinkage of the cells
was followed until complete and the temperature and
the pH of the cuvette’s contents were measured with
an Orion 811 pH meter.
The inhibitors of glucose transport, cytochalasin B
and phloretin were dissolved in methanol, made up in
phosphate-buffered saline to give a final concentra-
tion of methanol of -1%, and added directly to the
cuvette before the exit. The irreversible inhibitor,
 .1-fluoro-2,4-dinitrobenzene FDNB was also first
dissolved in 1% methanol and incubation of the cells
was carried out as described by Bowyer and Widdas
w x25 . 1,2-Cyclohexanedione was dissolved by adding
a small amount of 2N NaOH to the reagent, then
adding borate-buffered saline at pH 9.5, titrating with
more NaOH to maintain this pH. Incubations with
100 mM 1,2-cyclohexanedione were carried out as
w xdescribed by Baker and Widdas 19 .
2.3. Metabolic studies
As already described, 5% haematocrit suspensions
of washed red cells were incubated in the presence of
iodoacetamide and inosine. Samples were drawn at 0,
3, 6, 12, 24 and 30 h and washed. Aliquots of packed
cells were taken for ATP and intracellular potassium
determinations and for glucose exits. Control values
for ATP and exits were measured in cells incubated
in saline. ATP was assayed in neutralized perchloric
acid extracts. The extracts were prepared by mixing
0.15 ml of packed red cells with the same volume of
30% perchloric acid. After centrifugation at 4000=g
for 10 min, the supernatant was neutralized with 0.5 M
Tris-Cl and 0.5 M KOH and diluted 1 : 10 for subse-
quent use for ATP determinations. ATP was esti-
mated by the bioluminescent assay described by
w xSummerfield et al. 26 using an LKBrWallac 1250
Luminometer. Potassium determinations were made
by flame photometry of lysed packed cells. Glucose
exits in the presence, and in the absence, of 2 mM
cytochalasin B, were measured as described, after
resuspending the cells in 100 mM glucose for 1 h.
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2.4. Potassium experiments
Because ATP-depletion is associated with the loss
of potassium from the cells, two sets of preliminary
experiments were performed to see if this was likely
to affect the results. For one experiment, to reduce
potassium loss, both types of cell were suspended in
 .a high potassium phosphate buffer KCl 125 mM
and incubated with 100 mM of glucose as for ordi-
nary exits. In the other experiment, the possibility
that cell shrinkage following potassium loss might
have some effect was examined by incubating the
cells in hypertonic phosphate-buffered saline NaCl
.210 mM, 5 mM KCl . In both cases, the exit times
did not differ significantly from those of the control
cells and this approach was not continued.
2.5. Statistical analysis
Statistical analysis of the results was conducted
using MINITAB. Results are given as mean"S.E of
the mean.
3. Results
3.1. Depletion of ATP
Initially, cells were depleted for two to four hours
w xbefore use, as suggested in the literature 1,22 . How-
ever, no significant changes in exit times were seen.
We, therefore, followed the changes in exit time and
ATP concentration over 30 h. The results are shown
 .  .  .in Fig. 1 a and b . In Fig. 1 a , the logarithm of the
ATP concentration is plotted as a function of the time
of incubation in the presence of inosine and iodoacet-
amide. A dramatic decline in ATP levels is seen
during the first 6 h of incubation but, thereafter, a
 .much slower loss occurs. Fig. 1 b shows the corre-
sponding changes in the exit time for glucose. The
curve is roughly exponential and significant degrees
of inhibition are not seen until after nine-to-twelve
hours of incubation. Determinations of intracellular
potassium concentrations showed a slow fall over the
incubation time. At 24 and 30 h, there was a 15%
reduction in potassium within the cell sample, but
there was a significant degree of haemolysis also. For
this reason, it was decided to use a depletion time of
 .Fig. 1. Effect of incubation with a – iodoacetamide and inosine
 .on cellular ATP levels and b D-glucose exit times. Points are
means and s.e. of a minimum of three determinations at each
time point. Incubations were carried out at 208C and exits at
 .308C. The two lines in Fig. 1 a indicate the possibility of the
depletion being from two different pools see text for further
.details . Values in cells maintained in saline were not signifi-
cantly different from the initial values in both experiments.
18 h, drawing blood in the late afternoon and deplet-
ing the cells overnight for use the next day. This
protocol gave measurable changes in exit times but
negligible haemolysis.
3.2. Effect on exits
The inhibition of glucose exits by varying concen-
trations of glucose in the external medium was stud-
ied at 308C. Fig. 2 shows the Sen–Widdas plot of the
glucose exits in normal and in ATP-depleted cells.
The exit rate was slower in the depleted cells and the
apparent K for exits increased slightly from 2.5"m
0.1 mM in normal cells to 3.0"0.1 mM in the de-
 .pleted cells, P-0.01 . Preliminary experiments in
which the cells were loaded with the non-metabolisa-
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Fig. 2. Sen–Widdas plots of D-glucose exits from normal and
ATP-depleted cells into various external concentrations of D-glu-
cose. Cells were depleted for 18 h in 5 mM inosine and 5 mM
iodoacetamide at 208C to give an ATP concentration -1mM,
then loaded with 100mM D-glucose prior to exits. Points are
 .means and s.e. of six determinations at each concentration: I –
 .normal cells; and B – depleted cells.
ble sugar, 3-O-methylglucose, gave comparable shifts
in both, rate and affinity to those seen with glucose.
This confirms that the inhibition of glycolysis by
iodoacetamide was irreversible and ATP was not
being produced when depleted cells were loaded with
glucose.
3.3. Effect of transport inhibitors
To gain further information about the effect of
ATP-depletion, we examined the inhibition of glu-
Fig. 3. Effect of ATP-depletion on the inhibition of glucose exits
by cytochalasin B. The external D-glucose concentration was
0.7 mM. Points are means and s.e. of six determinations at each
 .  .concentration: I – normal cells; and B – depleted cells
w xATP -1mM.
Fig. 4. Lineweaver–Burk plot of the effect of ATP concentration
on glucose exit times in the presence, and absence, of 2 mM
cytochalsin B. Cells were incubated for various times with 5 mM
inosine and 5 mM iodoacetamide, then loaded with 100mM
D-glucose. The external glucose concentration was 0.7 mM. Points
are means and s.e. of a minimum of three determinations at each
 .  .concentration, I – control; and B – cytochalasin B.
cose exit by glucose transport inhibitors. Cytocha-
lasin B is regarded as the most specific inhibitor of
glucose transport. It reacts with the transporter at the
w xcytoplasmic face 17 where it binds reversibly with a
high affinity. Fig. 3 shows the inhibition of glucose
exits by cytochalasin B. The apparent inhibition con-
stant, K , decreases from 0.85"0.09 mM in the nor-i
mal cells to 0.51"0.06 mM in depleted ones P-
.0.01 . The results suggest that there may be competi-
tion between ATP and cytochalasin B for a site on
the glucose transporter, contrary to the observation of
w xCarruthers and Helgerson 7 .
Fig. 5. Effect of ATP-depletion on the inhibition of glucose exits
by phloretin. The external glucose concentration was 0.7 mM and
the points are means and s.e. of 6 determinations at each concen-
 .  . w xtration, I – normal cells; and B – depleted cells, ATP
-1mM.
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Table 1
The effect of treating normal and ATP-depleted red cells with fluorodinitrobenzene in the presence, and absence, of D-glucose. The
D-glucose exit times and % inhibitions are shown. Normal and depleted red cells were incubated in 1 mM FDNB with, or without 100 mM
glucose for 90 min at 258C. After treatment, cells were loaded with 100 mM glucose by incubation at 368C for 1 h. Values are the means
and standard errors of 10 determinations; % inhibitions are relative to controls
 .  .Control exit FDNB exit Inhibition % FDNBqGlucose Inhibition %
 .  .  .time s time s exit time s
Normal 23.0"0.7 51.8"5.6 50.6"4.9 135.2"23.0 75.9"4.0
ATP-Depleted 27.6"1.1 72.1"9.0 56.4"4.5 158.9"21.0 79.5"2.51
Table 2
The effect of treatment with 1,2-cyclohexanedione on D-glucose exit from red cells and on the inhibition produced by 2 mM cytochalasin
B. Glucose exit times in seconds determined on normal and ATP-depleted cells treated with 100 mM 1,2-cyclohexanedione for 30 min at
258C. Values are means and standard errors of 10 determinations; % inhibitions are relative to control cells, the values in brackets are
relative to dione-treated cells
Control exit Cytochalasin Dione treated Dione treatedq
 .times s 2 mM cytochalasin 2 mM
Normal 26.25"1.1 104"3.2 44.12"4.1 169.33"13.7
 .Inhibition — 75% 40% 85% 74%
ATP-Depleted 31.25"1.4 170"7.3 39.0"1.9 43.37"3.8
 .Inhibition — 82% 20% 28% 10%
This view is further supported by the results of the
ATP determination experiments. Fig. 4 shows a
Lineweaver–Burk plot relating the concentration of
ATP in the cells to the glucose exit time in the
presence, and absence, of cytochalasin B. The Kdapp.
for ATP in the normal cells was 0.43"0.05 mM, but
in the presence of 2 mM cytochalasin B, the Kdapp.
 .was increased to 0.68"0.08 mM, P-0.05 con-
firming a reduced affinity for ATP.
Fig. 5 shows the inhibition of glucose exits by
phloretin. The inhibition constant for phloretin in-
creased from 0.82"0.09 mM in the normal cells to
1.09"0.09 mM in depleted cells, but the effect was
 .small and not significant P)0.05 .
 .Fluorodinitrobenzene FDNB is an irreversible in-
hibitor of glucose transport. It was found by Bowyer
w xand Widdas 25 to be more effective when reacted in
w xthe presence of glucose, and Krupka 20 extended
this observation to demonstrate that binding was en-
hanced by the conformational change that occurs
with transfer. The effect of FDNB on glucose exits
from control and depleted cells is shown in Table 1.
Although the percentage inhibition is marginally
greater in depleted cells, both in the presence and in
the absence of glucose, the differences are not statis-
tically significant.
1,2-Cyclohexanedione reacts with, and modifies
w xarginine residues in proteins 27 and inhibits glucose
efflux from human red cells when incubated with
w xcells at high pH 19 . Table 2 shows the effect of
1,2-cyclohexenadione treatment on glucose exit from
control and ATP-depleted red cells. In both control
and ATP-depleted cells the exit rate was inhibited
after the treatment of cells with dione. However, the
ATP-depleted cells were less affected by dione and
although, as already shown, they had a higher affinity
for cytochalasin B when untreated, after dione treat-
ment their affinity for cytochalasin B was dramati-
cally reduced.
4. Discussion
4.1. Predicted effects of ATP-depletion
To our knowledge, this is the first study where the
effects of ATP-depletion on inhibitor binding to the
glucose transporter have been studied in intact human
erythrocytes. Although, there have been a number of
reports in the literature suggesting an interaction be-
tween the glucose transporter and ATP, it is not
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known if this represents a physiological role for the
nucleotide.
w xIn 1991, Widdas and Baker 15 suggested that
ATP might be responsible for maintaining the in-
tegrity of a cationic shield at the cytoplasmic side of
the transporter and, thus, preventing leakage of potas-
sium from the cells. Given this hypothesis is correct,
what effect would we expect ATP-depletion to have
on glucose transport? Since ATP is presumed to alter
the position of electrical charges within the trans-
porter, it would not be expected to have a significant
effect on the transport of a non-electrolyte like glu-
cose. However, it might alter the distribution of
inward and outward facing transporters since the
electrical attraction between the ATP and the arginine
residues would increase the energy requirements of
the conformational change. Thus, in the normal situa-
tion, when ATP is present we would expect that more
transporters would be facing outwards than inwards,
since we envisage ATP associating with the arginines
when the transporter is in the outward-facing confor-
mation. In depleted cells, we would expect relatively
more transporters to be facing inwards.
In agreement with most of the literature e.g. Refs.
w x.1,2,6 we find that cells containing ATP have a high
rate of glucose transport and that depletion of the
ATP content of the cells is associated with an in-
crease in the exit time. However, the effect is small
and intracellular ATP levels must be reduced to
nanomolar concentrations in order to significantly
affect glucose transport rates. In fact, we find that the
K of the transporter for ATP is only 430 nM.dapp.
This value is a hundred times lower than Carruthers’s
w x6 estimate of ;45mM. One explanation for this
w xdifference may lie in the suggestion of Hoffman 28
that there is a membrane-associated compartment of
ATP and it is with this that the glucose transporter is
equilibrating. Carruthers’s estimate was made using
inside-out vesicles exposed to known concentrations
of the nucleotide, but in our experiments we mea-
 .sured the ATP in the whole cell. As Fig. 1 b shows,
the concentration of ATP in the depleted cells de-
clined with time as a double exponential suggesting
the existence of two pools. The values of the inter-
cepts at zero time will give the relative amounts of
ATP in those pools. If the fast rate constant corre-
sponds to the depletion of the cytoplasmic pool and
the slow constant is for the membrane pool, the
intercepts suggest that the latter contains ;1r150th
the ATP of the former, in which case our value
would be in approximate agreement with Carruthers’s
estimate.
4.2. Effect of ATP-depletion on re˝ersible inhibitors
As well as lowering the rate of glucose exits, our
experiments showed that ATP-depletion lowered the
 .affinity of the transporter for glucose Fig. 2 . ATP
has been demonstrated to modify the K for D-glu-m
cose, but the effect depends on the flux that is
measured and there are disagreements between au-
w xthors. Thus, Jensen and Brahm 3 showed that the
K for exchange increased with ATP, while that form
 .net efflux zero-trans exit decreased. Hebert and
w xCarruthers 5 , on the other hand, found that the Km
for net efflux increased when ATP was added to red
w xcell ghosts. Carruthers 6 , has interpreted this result
as indicating that ATP reduces the K for D-glucosem
binding to the external site and increases it for bind-
ing to the internal site. Our findings agree with this
interpretation since the Sen–Widdas K is a mea-m
w xsure of the affinity of the external modifier site 29 .
The shift in affinities implies a redistribution of the
transporter with relatively more sites in the outward-
facing conformation when ATP is present. This redis-
tribution is consistent with a greater energy require-
ment for transformation from the outward to the
inward-facing position, as we predict. It explains
w xHebert and Carruthers’s 5 suggestion that the trans-
porter becomes asymmetrically in the presence of
ATP since the attraction between the electrical charges
of the ATP and arginines would reduce the work
required to face the transporter outwards and increase
the work necessary to return it to face the cytoplasm.
The distribution in the presence of ATP presum-
ably represents an optimal arrangement for exits and
any shift from this reduces the number of carriers
returning empty. Since it is the return of empty
carriers that determines net transfers, when the num-
bers fall there is a slowing of the exit rate.
In contrast to glucose, cytochalasin B showed a
significant increase in its affinity for the transporter
in depleted cells. Cytochalasin B acts at the cytoplas-
mic side of the glucose transporter and this result,
again, indicates that there are more transporters fac-
ing inwards in depleted cells. However, the relative
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change in affinity with cytochalasin B is twice as
great as that seen with inhibitors at the exofacial side
and the effect can also be interpreted as the result of
direct competition between ATP and cytochalasin B.
As Fig. 4 indicates, the rate of glucose exit is in-
versely related to the intracellular ATP concentration
and estimates of the K for ATP in the presence,dapp.
and absence, of cytochalasin B give values of
0.68 mM and 0.43 mM, respectively. Thus, cyto-
chalasin B does appear to interfere with ATP binding
w xto the transporter and vice versa. Clohery et al. 30
showed a reduction in the affinity of cytochalasin
binding to red cell ghosts in the presence of ATP but
the effect was not significant. The reason for this
difference between ghosts and intact cells is not clear.
4.3. Effect of ATP-depletion on irre˝ersible inhibitors
In the FNDB experiments, the slowing of glucose
efflux was greater in the depleted cells than in normal
cells, but the degree of inhibition relative to controls
 .was not significantly greater Table 1 . Thus, ATP
does not appear to have an effect on the events of the
conformational change.
In experiments with 1,2-cyclohexanedione, the in-
hibition of glucose exits reported by Baker and Wid-
w xdas 19 is confirmed but the effect of 1,2-cyclohe-
xanedione on the glucose exits from ATP-depleted
cells gave unexpected results, which are shown in
Table 2. In normal cells the percentage inhibition by
cytochalasin B is the same before, and after dione
treatment and the results suggest that there is no
interaction between the inhibitors. The total inhibition
with dione and cytochalasin is simply the sum of the
fraction of transporters modified by dione plus the
fraction of those unmodified which are blocked by
cytochalasin B. In ATP-depleted cells, the inhibition
by cytochalasin B is raised relative to that in normal
cells, as we have already shown, while the inhibition
due to dione is reduced. If the two inhibitors acted
independently of one another, the total inhibition in
cells treated with dione and cytochalasin B would be
about the same as that in normal cells. However, we
see that, in the ATP-depleted dione-treated cells, the
inhibition by cytochalasin B is dramatically reduced.
This indicates a reduction in cytochalsin B affinity
and, therefore, an interaction between the binding of
the two inhibitors.
In normal cells, it is assumed that the dione reacts
with the guanido groups of the arginines at the
cytoplasmic side of the transporter from within the
transport cleft. The resultant reaction products ob-
struct the movement of sugar. Plotting the data given
w xby Baker and Widdas 19 indicates that inhibition
increases with the square of the dione concentration
and that, therefore, two dione molecules are needed
to block the cleft. In this situation, access to the
cytochalasin B binding site is also prevented so that
cytochalasin can only bind to the unmodified trans-
porters. If the withdrawal of ATP, as occurs in the
depleted cells, simply lowered the transporter’s affin-
ity for dione perhaps by reducing the number of
.positive charges on the h-nitrogens of the arginines ,
then it would be expected that more transporters
would be available for cytochalasin B inhibition. But
this is clearly not the case.
One possible explanation is that ATP-depletion
permits cyclohexanedione to displace the arginine
residues from their normal position. This would allow
the reaction products to move away from the cleft so
that the channel was no longer obstructed. However,
this also implies that the position of the arginine
residues is important for cytochalasin B binding and
that, perhaps, as Baker and Widdas have suggested,
w xthe ring itself is the binding site 31 . Holman and
w xRees 32 have proposed that cytochalasin B binds
between domains 10 and 11. This region includes
R400 which is one of the arginines that could be in
the ring. The possibility that the integrity of the ring
is necessary for cytochalasin B binding is supported
w xby an observation of Baker et al. 15 . Treating
human red cells with 1,2-cyclohexanedione produces
a slow leak of potassium which is prevented if glu-
cose, maltose or phloretin is present during the reac-
tion. However, the leak cannot be prevented by react-
ing with cyclohexanedione in the presence of cyto-
chalasin B.
Clearly ATP affects the binding of inhibitors to the
cytoplasmic face of the glucose transporter and,
therefore, must bind as well. Carruthers and Helger-
w xson 7 have identified three potential binding sites in
the glucose transporter on the basis of consensus
sequences. Of these, two are of interest. One of the
 .sites residues 332–338 is thought to associate with
the triphosphate chain and contains the conserved
w xRRGXR sequence. Widdas and Baker 13 have pos-
( )M. Kaloyianni, G.F. BakerrBiochimica et Biophysica Acta 1369 1998 295–303 303
tulated that this sequence forms part of the ring and
the negatively charged triphosphate chain is that part
of ATP which is inserted into the ring to close it. It is
perhaps these arginines which are responsible for the
interaction between ATP and cyclohexanedione.
The other potential binding site of interest re-
.sidues 225–229 , which is proposed to react with the
adenosine ribose moiety of ATP, is located on the
cytoplasmic loop between domains 6 and 7. This part
of the transporter is sufficiently long and flexible to
be able to move in and out during the conformational
change, and could provide the point of attachment for
the nucleotide.
Thus, the possible binding sites for ATP are con-
sistent with its mechanism of action as proposed in
w xthe model of Widdas and Baker 14 , but in any case
the evidence of this study supports the view that ATP
binds to the cytoplasmic face of the GLUT1 trans-
porter and, in doing so, alters its distribution across
the membrane.
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